Recently [ElecrArc240] got his paws on an Intel-branded 3 kW power supply that apparently had been designed as a reference PSU for servers. At 3 kW in such a compact package air cooling would be ...

Final Fantasy 7 Rebirth is heading to the Switch 2 on June 3. The news was dropped at this morning's Nintendo Direct livestream. This is the second part of the FF7 remake-a-palooza. The first ...

The latest phase of the global law enforcement action resulted in seizing three industrial-scale illegal IPTV services. The operation, coordinated by Europol, Eurojust, and Interpol, was led by ...

Topline Data from Three Phase 3 Studies Evaluating DT120 Orally Disintegrating Tablet (ODT) for GAD and MDD Expected in 2026: Voyage in 2Q, Panorama in 2H, and Emerge Mid-Year Company Presenting at ...

Animal Crossing: New Horizon fans, rejoice! The original Nintendo Switch’s second-best-selling game is getting new content in 2026, almost six years after its original launch – and a Switch 2 port, ...

Mini-Circuits integrate Menlo Microsystems’ Ideal Switch technology into their MEM-SP4T A18 absorptive switch to increase performance and address new wireless applications Mini-Circuits has a long ...

With a modular design that supports up to 100kW of DC fast charging output, this new collaborative charging platform gives businesses, municipalities, and fleet operators a scalable solution to ...

Abstract: Open-circuit faults increase estimated rotor position errors in conventional sensorless control methods of dual three-phase permanent magnet synchronous motors due to the distortions of ...

Regeneron is racing to regulators after reporting a phase 3 win in an ultrarare disease. The biotech plans to file for FDA approval of garetosmab in fibrodysplasia ossificans progressiva (FOP) by the ...

(NEXSTAR) – A multi-phase scam credited with emptying the financial accounts of numerous Americans – many of whom were nearing the age of retirement – is again making headlines after the FBI recently ...

The current Alzheimer’s disease therapeutic antibodies carry a sizable risk of ARIA, especially for APOE4 carriers. Researchers believe the future of amyloid immunotherapies lies in targeted brain ...